Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virus - Mwakyandile, Tosi M.; Shayo, Grace A.; Sasi, Philip G.; Mugusi, Ferdinand M.; Barabona, Godfrey; Ueno, Takamasa; Lyamuya, Eligius F. (BMC infectious diseases, 2024)
Keywords: Acquired immune deficiency syndrome; Adult; AIDS; Antiretroviral agents; Antiretroviral drugs; Antiretroviral therapy; Antiviral agents; Aspirin; Biomarkers - blood; Body mass index; Body size; Cardiovascular diseases; Care and treatment; CD14 antigen; CD38 antigen; Complications and side effects; Dosage and administration; Female; Flow cytometry; Glomerular filtration rate; HIV; HIV infection; HIV Infections - complications; HIV Infections - drug therapy; HIV Infections - immunology; Human immunodeficiency virus; Humans; Hypertension; Hypertension - drug therapy; Hypertension - immunology; Laboratories; Lipopolysaccharide Receptors - blood; Lymphocyte activation; Lymphocytes; Lymphocytes T; Male; Middle Aged; Monocyte activation; Mortality; Pathogenesis; PD-1 protein; Population studies; Prevention; Regression models; Risk factors; Africa; China; Japan; Tanzania; Hypertension; Lymphocyte activation; HIV; Monocyte activation; Antiretroviral therapy